Solventum initiated with a Hold at Jefferies

Jefferies analyst Michael Toomey initiated coverage of Solventum (SOLV) with a Hold rating and $80 price target The firm believes the company has successfully reshaped its portfolio, cut costs and is positioned for 2%-3% organic growth in 2025. Solventum’s “back-loaded” earnings growth will limit a re-rating of the shares, the analyst tells investors in a research note.